TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 17.74%1.18B | 38.70%2B | 80.31%1B | 110.14%1.44B | 74.07%556.12M | 101.75%686.53M | 90.78%319.48M | 1,711.91%340.29M | 1,974.57%167.46M | 23.36%18.78M |
Operating income | 17.74%1.18B | 38.70%2B | 80.31%1B | 110.14%1.44B | 74.07%556.12M | 101.75%686.53M | 90.78%319.48M | 1,711.91%340.29M | 1,974.57%167.46M | 23.36%18.78M |
Cost of sales | -10.91%-676.52M | -35.08%-1.15B | -87.15%-609.98M | -152.24%-851.96M | -109.24%-325.94M | -93.30%-337.76M | -86.67%-155.77M | -3,178.85%-174.73M | -5,523.38%-83.45M | -77.57%-5.33M |
Operating expenses | -10.91%-676.52M | -35.08%-1.15B | -87.15%-609.98M | -152.24%-851.96M | -109.24%-325.94M | -93.30%-337.76M | -86.67%-155.77M | -3,178.85%-174.73M | -5,523.38%-83.45M | -77.57%-5.33M |
Gross profit | 28.35%504.12M | 43.92%850.16M | 70.63%392.77M | 69.37%590.71M | 40.61%230.19M | 110.66%348.77M | 94.87%163.71M | 1,130.78%165.56M | 1,175.17%84.01M | 10.05%13.45M |
Selling expenses | -31.26%-152.46M | -87.47%-284.86M | -135.85%-116.15M | -55.27%-151.95M | -34.68%-49.25M | -30.90%-97.86M | -19.84%-36.57M | -897.09%-74.76M | -735.34%-30.52M | -31.84%-7.5M |
Administrative expenses | -19.34%-93.65M | -24.65%-203.08M | -36.61%-78.47M | -26.45%-162.91M | -70.47%-57.44M | -121.37%-128.84M | -62.17%-33.7M | -425.70%-58.2M | -515.10%-20.78M | -46.38%-11.07M |
Research and development expenses | -49.97%-142.9M | -73.92%-231.53M | -63.59%-95.29M | -19.04%-133.13M | -19.80%-58.25M | -113.08%-111.84M | -154.33%-48.62M | -1,998.68%-52.49M | -1,813.71%-19.12M | -58.59%-2.5M |
Operating interest expense | ---- | ---- | ---- | ---- | -89.06%-22.51M | 59.81%-20.17M | ---11.91M | ---50.19M | ---- | ---- |
Special items of operating profit | 110.25%758K | -79.62%8.7M | -166.14%-7.4M | 673.88%42.69M | 507.77%11.18M | -96.13%5.52M | -97.59%1.84M | 76,498.39%142.47M | 238,546.88%76.37M | 135.44%186K |
Operating profit | 21.37%115.87M | -24.82%139.39M | 77.06%95.47M | 4,286.20%185.41M | 55.14%53.92M | -106.12%-4.43M | -61.37%34.75M | 1,074.07%72.39M | 6,480.43%89.96M | -194.45%-7.43M |
Financing cost | 8.54%-46.03M | 0.56%-92.25M | ---50.33M | ---92.77M | ---- | ---- | ---- | ---- | -84,226.09%-19.4M | ---649K |
Share of profits of associates | ---- | 101.08%1K | 100.69%1K | 13.89%-93K | ---145K | ---108K | ---- | ---- | ---- | ---- |
Special items of earning before tax | ---- | ---- | ---- | ---- | -134.54%-8.78M | -96.75%-10.34M | ---3.74M | ---5.26M | ---- | ---- |
Earning before tax | 54.72%69.83M | -49.06%47.14M | 0.32%45.14M | 722.09%92.54M | 45.09%44.99M | -122.16%-14.88M | -56.06%31.01M | 930.81%67.14M | 5,024.56%70.57M | -220.17%-8.08M |
Tax | -109.78%-23.51M | -37.49%-47.35M | 29.28%-11.21M | -341.47%-34.44M | -99.46%-15.85M | -155.53%-7.8M | -352.38%-7.95M | 650.88%14.05M | 877.64%3.15M | 8,404.55%1.87M |
After-tax profit from continuing operations | 36.53%46.32M | -100.36%-210K | 16.41%33.93M | 356.22%58.1M | 26.36%29.15M | -127.93%-22.68M | -68.71%23.07M | 1,407.36%81.19M | 6,735.19%73.72M | -148.20%-6.21M |
Earning after tax | 36.53%46.32M | -100.36%-210K | 16.41%33.93M | 356.22%58.1M | 26.36%29.15M | -127.93%-22.68M | -68.71%23.07M | 1,407.36%81.19M | 6,735.19%73.72M | -148.20%-6.21M |
Minority profit | 1.74%4.85M | -52.75%7.61M | -13.08%4.77M | --16.1M | --5.48M | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | 42.21%41.47M | -118.61%-7.82M | 23.24%29.16M | 285.22%42M | 2.59%23.66M | -127.93%-22.68M | -68.71%23.07M | 1,407.36%81.19M | 6,735.19%73.72M | -148.20%-6.21M |
Basic earnings per share | 39.39%0.0184 | -117.68%-0.0035 | 17.86%0.0132 | 266.39%0.0198 | -9.68%0.0112 | -125.11%-0.0119 | -92.85%0.0124 | 424.66%0.0474 | 6,769.23%0.1734 | -147.46%-0.0146 |
Diluted earnings per share | 41.32%0.0171 | -117.86%-0.0035 | 18.63%0.0121 | 264.71%0.0196 | -12.82%0.0102 | -125.93%-0.0119 | -93.10%0.0117 | 414.38%0.0459 | 6,623.08%0.1696 | -147.46%-0.0146 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | USD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.